Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -20.36%19.14M | -22.37%9.97M | -31.75%24.03M | -22.74%12.84M | 86.29%35.21M | 123.53%16.62M | -19.33%18.9M | -44.27%7.43M | -8.81%23.43M | 75.21%13.34M |
| Operating income | -20.36%19.14M | -22.37%9.97M | -31.75%24.03M | -22.74%12.84M | 86.29%35.21M | 123.53%16.62M | -19.33%18.9M | -44.27%7.43M | -8.81%23.43M | 75.21%13.34M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---2.09M | ---- | ---- | ---- |
| Employee expense | -17.38%-14.04M | 17.87%-5.16M | 10.81%-11.96M | -2.14%-6.28M | -19.42%-13.41M | -10.41%-6.15M | 6.03%-11.23M | 18.68%-5.57M | 1.87%-11.95M | -16.85%-6.85M |
| Depreciation and amortization | 9.49%-5.21M | 11.70%-2.6M | 11.88%-5.76M | 10.40%-2.95M | 4.45%-6.54M | 3.61%-3.29M | 5.56%-6.84M | 2.83%-3.41M | -1.05%-7.24M | 0.42%-3.51M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.39%-20.62K | 57.98%-28.99K | ---19.57K |
| Special items of operating profit | 55.64%-12.5M | 175.84%18M | 26.19%-28.19M | -264.19%-23.74M | -140.47%-38.19M | -1,062.85%-6.52M | -569.44%-15.88M | -80.64%676.96K | 32,944.56%3.38M | 433.97%3.5M |
| Operating profit | 42.32%-12.62M | 200.41%20.21M | 4.59%-21.87M | -3,144.53%-20.13M | -33.79%-22.93M | 174.24%661.07K | -325.82%-17.14M | -113.79%-890.5K | 21.12%7.59M | 677.42%6.46M |
| Financing cost | 40.42%-50.37K | -17.22%-33.9K | -41.24%-84.54K | 23.55%-28.92K | 38.13%-59.86K | ---37.82K | ---96.74K | ---- | ---- | ---- |
| Share of profits of associates | 77.98%-2.45M | -37.53%-1.51M | -1,351.57%-11.15M | -123.20%-1.1M | -117.73%-768.07K | -115.57%-491.62K | -41.02%4.33M | -23.77%3.16M | -24.13%7.35M | -2.80%4.14M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 32.37%-5.54M | 17.44%-12.25M | -56.19%-8.19M |
| Earning before tax | 54.33%-15.12M | 187.83%18.67M | -39.37%-33.11M | -16,245.85%-21.25M | -84.13%-23.76M | 104.03%131.63K | -580.84%-12.9M | -235.52%-3.27M | 142.10%2.68M | 212.88%2.41M |
| Tax | ---- | ---- | ---- | ---- | 165.86%926.17K | 65.18%375.66K | -246.88%-1.41M | -46.59%227.43K | 4.17%957.45K | 40.14%425.83K |
| After-tax profit from continuing operations | 54.33%-15.12M | 187.83%18.67M | -45.03%-33.11M | -4,289.43%-21.25M | -59.56%-22.83M | 116.68%507.29K | -493.01%-14.31M | -207.17%-3.04M | 79.57%3.64M | 254.81%2.84M |
| Earning after tax | 54.33%-15.12M | 187.83%18.67M | -45.03%-33.11M | -4,289.43%-21.25M | -59.56%-22.83M | 116.68%507.29K | -493.01%-14.31M | -207.17%-3.04M | 79.57%3.64M | 254.81%2.84M |
| Profit attributable to shareholders | 54.33%-15.12M | 187.83%18.67M | -45.03%-33.11M | -4,289.43%-21.25M | -59.56%-22.83M | 116.68%507.29K | -493.01%-14.31M | -207.17%-3.04M | 79.57%3.64M | 254.81%2.84M |
| Basic earnings per share | 54.33%-0.0132 | 187.63%0.0163 | -45.23%-0.0289 | -4,750.00%-0.0186 | -59.20%-0.0199 | 114.81%0.0004 | -490.63%-0.0125 | -208.00%-0.0027 | 77.78%0.0032 | 256.25%0.0025 |
| Diluted earnings per share | 54.33%-0.0132 | 187.63%0.0163 | -45.23%-0.0289 | -4,750.00%-0.0186 | -59.20%-0.0199 | 114.81%0.0004 | -490.63%-0.0125 | -208.00%-0.0027 | 77.78%0.0032 | 256.25%0.0025 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm | -- | National Health Accounting Firm | -- | National Health Accounting Firm | -- | National Health Accounting Firm | -- | National Health Accounting Firm | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.